Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Colorcon
McKesson
Moodys
Harvard Business School
Merck

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Litigation Details for GILEAD SCIENCES, INC. v. Mylan Inc. (N.D.W. Va. 2014)


Email this page to a colleague

« Back to Dashboard

Small Molecule Drugs cited in GILEAD SCIENCES, INC. v. Mylan Inc.
Biologic Drugs cited in GILEAD SCIENCES, INC. v. Mylan Inc.
The biologic drug covered by the patents cited in this case is ⤷  Free Forever Trial .

Details for GILEAD SCIENCES, INC. v. Mylan Inc. (N.D.W. Va. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-06-09 1 30. United States Patent No. 6,642,245 (“the ’245 Patent,” copy attached as Exhibit A),… Infringement of U.S. Patent No. 6,642,245 40. Plaintiffs repeat…Exhibit A - Patent Information, # 2 Exhibit A/Pt. 2 - Patent Information, # 3 Exhibit B - Patent Information…Information, # 4 Exhibit C - Patent Information, # 5 Exhibit C/Pt. 2 - Patent Information, # 6 Civil Cover Sheet… 1. This is an action for patent infringement under the patent laws of the United States, Title External link to document
2015-03-02 105 infringement of U.S. Patent Nos. 6,642,245 (the “’245 patent”), 6,703,396 (the “’396 patent”), and 8,592,397…infringement of a fourth patent, U.S. Patent No. 8,716,264 (the “’264 patent”). (D.I. 94.) (The ‘245… ‘396 patents are referred to herein as the “FTC Patents,” and the ‘397 and ‘264 patents are referred…before the United States Patent and Trademark Office of the patent applications leading to…before the United States Patent and Trademark Office of the patent applications leading to External link to document
2015-03-02 106 United States Patent and Trademark Office (“USPTO”) issued United States Patent No. 6,642,245 (the “’245… ’245 patent, including but not limited to the right to sue for infringement of the ’245 patent. …the USPTO issued United States Patent No. 6,703,396 (the “’396 patent”), entitled “Method of Resolution… ’396 patent, including but not limited to the right to sue for infringement of the ’396 patent. …the USPTO issued United States Patent No. 8,592,397 (the “’397 patent”), entitled “Compositions and Methods External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Baxter
Express Scripts
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.